Clinical Trials Directory

Trials / Completed

CompletedNCT00623610

Beta-Cell Transplantation in Pre-Uremic Patients With Type 1 Diabetes

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Universitair Ziekenhuis Brussel · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To examine whether temporary immunosuppression with ATG, tacrolimus and MMF allows prolonged survival of beta cell allografts in type 1 diabetic patients with early chronic complications of diabetes.

Conditions

Interventions

TypeNameDescription
PROCEDUREislet cell graftsIntraportal injection of an islet cell graft into the liver.

Timeline

Start date
2000-09-01
Primary completion
2005-10-01
Completion
2005-10-01
First posted
2008-02-26
Last updated
2008-02-26

Locations

2 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00623610. Inclusion in this directory is not an endorsement.

Beta-Cell Transplantation in Pre-Uremic Patients With Type 1 Diabetes (NCT00623610) · Clinical Trials Directory